PRIME (priority medicines) Eligibility Requests

On October 4, 2019 EMA announced deadlines for submission and timetable for assessment in 2020

PRIME is a scheme launched by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier.

Read the pdf
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /